ISSN: 2153-0645
Journal of Pharmacogenomics & Pharmacoproteomics received 613 citations as per Google Scholar report
Opinion Article
Toxicoproteomics and Biomarker in the Study of Liver Disease
DOI: 10.35248/2153-0645.22.13.015
Commentary
Epigenomics: An Approach to Understand Complex Diseases
DOI: 10.35248/2153-0645.22.13.014
Mechanism of Action of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
DOI: 10.35248/2153-0645.22.13.013
Perspective
Novel Drug Delivery System (NDDS) of Metformin
DOI: 10.35248/2153-0645.22.13.012
Pharmacogenomics and Drug Responses in Children
DOI: 10.35248/2153-0645.22.13.011
Short Communication
Genetic Polymorphisms in CYP2C9 and the Variability in Warfarin Response Among South Asian Populations
DOI: 10.4172/2153-0645.25.16.123
SLCO1B1 Polymorphisms and Statin-Induced Myopathy: A Clinical Pharmacogenomic Perspective
DOI: 10.4172/2153-0645.25.16.127
Pharmacogenomic Insights into HLA-B*15:02 Mediated Carbamazepine-Induced Stevens-Johnson Syndrome
DOI: 10.4172/2153-0645.25.16.128
TPMT and NUDT15 Genetic Variants in Azathioprine Therapy for Autoimmune Disorders
DOI: 10.4172/2153-0645.25.16.129
Impact of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Patients
DOI: 10.4172/2153-0645.25.16.130
COMT Val158Met Polymorphism and Its Influence on Dopaminergic Drug Response in Schizophrenia
DOI: 10.4172/2153-0645.25.16.132
Influence of ABCB1 Gene Variants on Antidepressant Response in Major Depressive Disorder
DOI: 10.4172/2153-0645.25.16.124
Role of UGT1A1 Polymorphism in Irinotecan-Induced Toxicity in Colorectal Cancer Treatment
DOI: 10.4172/2153-0645.25.16.125
Impact of CYP2D6 Polymorphism on Tamoxifen Efficacy in Estrogen Receptor-Positive Breast Cancer
DOI: 10.4172/2153-0645.25.16.126
Pharmacogenetic Variants in DPYD and the Risk of Fluoropyrimidine Toxicity in Cancer Therapy
DOI: 10.4172/2153-0645.25.16.131